Buy Pfizer (PFE) Stock for a Rebound After Crushing Q1 EPS Expectations?Zacks Investment Research • 04/30/25
Pfizer could make ‘tremendous investments' in the US, but here's why it's choosing not toInvezz • 04/29/25
Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&DCNBC • 04/29/25
Compared to Estimates, Pfizer (PFE) Q1 Earnings: A Look at Key MetricsZacks Investment Research • 04/29/25
If You'd Invested $10,000 in Pfizer Stock 10 Years Ago, Here's How Much You'd Have TodayThe Motley Fool • 04/29/25
Pfizer Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate AnalystsBenzinga • 04/29/25
Pfizer's Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder CancerBusiness Wire • 04/26/25
Exclusive: US pharma tariffs would raise US drug costs by $51 bln annually, report findsReuters • 04/25/25